2 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Cryoglobulinemic Vasculitis (CV): new trials by email Literature Review of Cryoglobulinemic Vasculitis (CV) trials Research Report on Cryoglobulinemic Vasculitis (CV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab Obinutuzumab - Cryoglobulinemic Vasculitis (CV) | Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | 30 | 2026-01-30 | 2026-08-31 |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis | Recruiting | Peter Merkel | 50 | 2017-01-01 | 2026-01-22 |
Cryoglobulinemia, Familial Mixed (2) · Churg-Strauss Syndrome (1) · Granulomatosis with Polyangiitis (1) · IgA Vasculitis (1) · Microscopic Polyangiitis (1) · Polyarteritis Nodosa (1) · Vasculitis (1)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arteritis (1) · Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Granuloma (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1)
obinutuzumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Peter Merkel (1)
Canada (1) · France (1) · United States (1)
Peter Grayson, MD, MSc (1) · Robert Micheletti, MD (1)
U54AR057319 (1)